Prakt. lékáren. 2009; 5(3): 130-134

Pharmacotherapy of chronic pain

MUDr. Petr Ševčík, Ph.D1, MUDr. Hana Vacovská2, MUDr. Vladimír Rohan2, MUDr. Jiří Polívka CSc3
1 Fakultní nemocnice Plzeň
2 Neurologická klinika LF UK a FN Plzeň
3 Neonatologické oddělení, FN a LF UK, Plzeň

Effective treatment of chronic pain may significantly improve the quality of life. A brief overview of its mechanisms of origin and of

pharmacological treatment options is presented. Nonsteroidal anti-inflammatory drugs (NSAIDs) are the mainstay of treatment of

numerous causes of pain. However, they can cause bleeding into the stomach. Cyclooxygenase-2 (COX-2) inhibitors have a lower risk of

bleeding than nonselective COX inhibitors; however, they may not be more effective. A therapeutic trial with various NSAIDs may identify

an appropriate drug which is most effective in a particular patient. Although physicians are often reluctant to prescribing opioids

for chronic pain, using these drugs while clearly determining the goals and thoroughly monitoring the course of the treatment is appropriate.

Tricyclic antidepressants, anticonvulsants, psychopharmaceuticals, and other drugs play an important role in the treatment

of chronic and, in particular, neuropathic pain.

Keywords: pain, chronic pain, nonsteroidal anti-inflammatory drugs, NSAIDs, COX-2, opioids, antidepressants, anticonvulsants, psychopharmaceuticals.

Published: May 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ševčík P, Vacovská H, Rohan V, Polívka J. Pharmacotherapy of chronic pain. Praktické lékárenství. 2009;5(3):130-134.
Download citation

References

  1. Singh G. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am J Med 1998; 105(suppl 1B): 31S-38S. Go to original source... Go to PubMed...
  2. McCormack K, Brune K. Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs. A survey of their analgesic efficacy. Drugs 1991; 41: 533-547. Go to original source... Go to PubMed...
  3. Breivik EK, Barkvoll P, Skovlund E. Combining diclofenac with acetaminophen or acetaminophen-codeine after oral surgery: a randomized, double-blind single-dose study. Clin Pharmacol Ther 1999; 66: 625-635. Go to original source... Go to PubMed...
  4. Simmons DL, Botting RM, Robertson PM, Madsen ML, Vane JR. Induction of an acetaminophen-sensitive cyclooxygenase with reduced sensitivity tononsteroid antiinflammatory drugs. Proc Natl Acad Sci USA 1999; 96: 3275-3280. Go to original source... Go to PubMed...
  5. Portenoy RK. Chronic opioid therapy in nonmalignant pain. J Pain Sympt Manage 1990; 5: S46-S62.
  6. Hill CS Jr. Relationship among cultural, educational, and regulatory agency influences on optimum cancer pain treatment. J Pain Sympt Manage 1990; 5(suppl 1): S37-S45.
  7. McNairy SL, Maruta T, Ivnik RJ, Swanson DW, Ilstrup DM. Prescription medication dependence and neuropsychologic function. Pain 1984; 18: 169-177. Go to original source... Go to PubMed...
  8. Fordyce WE. Behavioral concepts in chronic pain and illness. In: Davidson PO, editor: The Behavioral Management of Anxiety, Depression and Pain. New York: Brunner/Mazel, 1975: 147-188.
  9. Brena SF, Sanders SH. Opioids in nonmalignant pain: questions in search of answers. Clin J Pain 1991: 7: 342-345. Go to original source...
  10. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999; 83: 389-400. Go to original source... Go to PubMed...
  11. Taylor CP, Gee NS, Su TZ, et al. A summary of mechanistic hypothesis of gabapentin pharmacology. Epilepsy Res 1998; 29: 233-239. Go to original source... Go to PubMed...
  12. Portenoy RK. Current pharmacotherapy of chronic pain. J Pain Symptom Manage 2000; 19 (suppl): 516-520. Go to original source... Go to PubMed...




Pharmacy for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.